Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024Marine Maurel, Jennifer Howard, Esther Kissling et al.|Eurosurveillance|2024Cited by 50
Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre studyMarine Maurel, Alina Elena Ivanciuc, Aurora López et al.|Influenza and Other Respiratory Viruses|2024Cited by 28
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021Esther Kissling, Mariëtte Hooiveld, Iván Martínez‐Baz et al.|Eurosurveillance|2022Cited by 27
Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderlyIrina Kislaya, Baltazar Nunes, Ana Paula Rodrigues et al.|PLoS ONE|2019Cited by 22
Monitoring COVID‐19 and Influenza: The Added Value of a Severe Acute Respiratory Infection Surveillance System in PortugalAna Rita Torres, Ausenda Machado, Verónica Gomez et al.|Canadian Journal of Infectious Diseases and Medical Microbiology|2023Cited by 18